# AZD5672 Absolute Bioavailability Study

> **NCT00746837** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 26 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AZD5672
- **DRUG:** AZD5672
- **DRUG:** AZD5672

## Key facts

- **NCT ID:** NCT00746837
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2010-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00746837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00746837, "AZD5672 Absolute Bioavailability Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00746837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*